Are Letters of Intent Required?
October 28, 2019
No, letters of intent are not required. Submission of a letter of intent is not binding and the letter is not part of the application review.
My resubmission of a competing renewal application (Type 2 A1) was not funded. May I submit a new renewal (Type 2 A0)?
April 25, 2019
No. Only a single resubmission of a competing new, revision, or renewal application (A0) will be accepted. After a resubmission of a competing renewal (Type 2) application that is not funded, a subsequent new renewal (Type 2 A0) application may not be submitted. The next application submitted on this topic should be submitted as a new application (Type 1 A0) on an appropriate due date for new applications (see NOT-OD-18-197 for exceptions).
4 Comments
Where Should I Address the Inclusion Across the Lifespan Policy in My Application?
March 25, 2019
Applicants should include a rationale for the age range of study participants and justification for age-based exclusion in the Inclusion of Women, Minorities, and Children section of the PHS Human Subjects and Clinical Trials Information Form (Section 2.4). This section will continue to have the heading “Inclusion of Women, Minorities, and Children” until the next forms update. See the instructions under Inclusion of Children in the application guide for additional information.
0 Comments
Still Have Questions on the NIH Early Stage Investigator (ESI) Policy?
March 1, 2019
Looking for answers to your questions on our Early Stage Investigator (ESI) policy? Check out the following highlighted frequently asked questions (FAQ) for information on how NIH defines and reviews ESI applications to promote the growth and stability of the biomedical research workforce.
88 Comments
How Do I Determine if My Institution is Eligible For an R15 Research Enhancement Award?
January 7, 2019
As of January 24, 2019, NIH will no longer maintain its list of institutions ineligible to apply for R15 grants. Instead, for R15 applications submitted for due dates on or after February 25, 2019, institutions are responsible for determining their own eligibility. Institutions can determine eligibility using the NIH RePORT website.
3 Comments
Can My Application be Considered a Resubmission Even if I am Not Re-Submitting to the Same FOA?
December 12, 2018
It depends on whether the FOAs are Program Announcements (PA, PAR, PAS or Parent) or Requests for Applications (RFA).
1 Comments
You Had Clinical Trial K Application Questions, We Have Answers
August 7, 2018
Are you submitting a K application? Check out some new frequently asked questions (FAQs).
1 Comments
Are Studies Ancillary to Clinical Trials Considered to be Clinical Trials As Well?
August 7, 2018
It depends. Yes; if the ancillary study adds an additional prospectively assigned intervention to patients or a sub-population of patients within the larger clinical trial and all elements of the NIH clinical trial definition are met. No; if the ancillary study is only adding additional measures to an existing clinical trial.
0 Comments
In the RPPR, do we need to fill out the Human Subjects and Clinical Trials Information form if we submitted a competing application before January 25, 2018?
July 24, 2018
The Human Subjects and Clinical Trials Information form appears for all recipients with human subjects studies. However, those who submitted competing applications for due dates on or before January 25, 2018 only need to update inclusion data via the Human Subjects link in the RPPR. The remaining fields (e.g. milestones) are not required to be … Continue reading “In the RPPR, do we need to fill out the Human Subjects and Clinical Trials Information form if we submitted a competing application before January 25, 2018?”
2 Comments
After My Application is Submitted, Can I Include a Copy or Citation of a Preprint as Post-submission Materials?
March 2, 2018
No. Pre-prints are not included in the list of allowable post-submission materials, because they do not fall in the category of unanticipated events.
Post-submission materials are not intended to correct oversights or errors discovered after submission of the application, but rather ….
5 Comments
2 Comments